Mizuho cuts Mosaic stock price target on margin pressures

Mosaic reported Q3 2026 adjusted EBITDA of $324 million, down 60% year over year and below the $342 million consensus; adjusted EPS was -$0.19 versus -$0.03 expected and $1.04 a year earlier. Mizuho cut its price target to $20 from $22 and kept a Neutral rating, citing weaker Phosphate and Potash results; rising input costs and scarce sulfur tied to the Iran conflict are pressuring margins and limiting phosphate production. DAP and MOP prices were within company guidance, but gross margin was 11% and trailing-12-month EPS was -$2.01.

Analysis

The key issue is conversion, not headline fertilizer pricing: when sulfur and other inputs are scarce, higher phosphate realizations need not translate into better segment earnings. If Mosaic maintains curtailed output, fixed-cost absorption can further delay margin repair; a rebound in quoted DAP prices alone is therefore a weak catalyst. Near term, the risk/reward looks skewed to further estimate cuts unless the next update shows improving phosphate contribution and reliable raw-material availability. Over 1–3 months, monitor sulfur sourcing and phosphate segment results; over 6–18 months, any sustained supply normalization could restore output, but affordability limits how much fertilizer pricing can be passed through to farmers. A Belarus potash arrangement is a potential price headwind for producers only if it becomes executable and logistics or sanctions constraints ease; an announcement alone is not a supply shock. Consensus may be underweight the duration of phosphate margin pressure, but analyst target dispersion and the already weak operating backdrop argue against treating the downgrade itself as a fresh short catalyst. Falsifiers: improving phosphate segment profitability despite constrained inputs, restored production guidance, or evidence that raw-material availability is normalizing.

Key Decisions for Investors

• Keep MOS underweight; consider initiating a small short on a relief rally rather than chasing weakness. Reassess after the next operating update, with phosphate segment contribution and production guidance as the key tests.
• A relative-value expression is short Mosaic against long Nutrien, sized to limit broad fertilizer-price exposure: the thesis is Mosaic's greater sensitivity to phosphate input constraints, while Nutrien has a more diversified business mix. Verify current segment exposures and valuation before entry; shared potash exposure can dilute the hedge.
• Treat any Belarus-related potash supply news as a conditional catalyst, not a base case. Reduce the bearish stance if export logistics materially reopen and Mosaic reports improved input availability or phosphate margins.
• No options trade is warranted from this information alone: missing are current MOS price/option-implied volatility, balance-sheet liquidity detail, and the market's current earnings expectations.